2Weinberger K M,Wiedenmann E,Bohm S, et al. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system(Taq Man PCR)[J]. Journal Virol Methods, 2000, 85 (1-2) : 75.
3Khakoo S I,Soni P N, Brown D,et al . A clinical evaluation of a new method for HBV DNA quantitation in patients with chronic hepatitis B virus[J]. Journal of Medical Virology,1996,50(2) : 112.
4Kim JW, Lee HS, Woo GH, et al. Fatal submassive hepatic necrosis associated with tyrosine- methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. Clin Infect Dis, 2001, 33: 403-405.
5Lin X, Yuan ZH, Wu L, et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol, 2001, 75:11827-11833.
6Allen MI, Deslauriers M, Andrew CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology, 1998, 27:1670-1677.
7Liu C J, Chen PJ, Lai MY, et al. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.Heoatology, 2001,34 : 583-589.
8Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replicationd efective. Hepatology, 1998,27:628-633.
9Boek CT, Tillmann, HL, Torresi J, et al. Selection of hepatitis B virus polyrnerase mutants with enhanced replication by tamivudine treatment after liver transplantation. Gastroenterology,2002, 122: 264-273.
10Oho SK, Karo N, Shiratori Y, et al. The polymerase L528M mutation cooperates with nucleotide binding-site mutations increasing hepatitis B virus replication and drug resistance. J Clin Invest, 2001,107:449-455.
